Close
We strive to secure a market-competitive level of compensation, taking in...
As part of Deciphera’s Global All Company Meeting in October 2025, em...
Targets Progress Initiatives Initiatives for Pharmaceuticals Ext...
Governance Strategy Risk and opportunity management Indicators and...
Our Position on Biodiversity Initiatives to Reduce Negative Impacts ...
Environment Global Policy Medium- to Long-term Environmental Vision ...
Information Disclosure IR Activities ESG Activities
Basic Policy for Enterprise Risk Management (ERM) In order to ensu...
Our Materiality Steps in materiality analysis Sustainability Promo...
Basic approach Pursuit of fair promotion activities Management sys...
Environmental Costs (Including Depreciation Costs) (Thousands o...
We are moving ahead with activities to achieve our medium- to long-ter...
Please refer to the “Corporate Governance Report” below for details on ou...
We have established a Business Continuity Plan (BCP) to ensure that, even...
We implement all the principles of the Corporate Governance Code stipulat...
As for water risks, the Environmental Management Committee and the Nature...
There are still countries and regions in the world where the healthcare i...
Corporate Governance Structure Corporate Governance Code Corporate...
When we outsource animal experiments, we ensure that the outsourcing cont...
ONO Pharmaceutical’s Compliance System Initiatives to Strengthen Comp...
Professional Human Resources are individuals who possess the skills a...
We aim to be an organization that embraces diversity in human capital ...
We conduct environmental efficiency assessments to quantitatively measure t...
